€65.00
0.62% today
Xetra, Feb 05, 04:07 pm CET
ISIN
DE000A2YNT30
Symbol
ACT
Index
Industry

Alzchem Group Stock price

€64.60
+2.60 4.19% 1M
+14.00 27.67% 6M
+7.60 13.33% YTD
+41.64 181.33% 1Y
+44.65 223.78% 3Y
+47.74 283.19% 5Y
+49.84 337.72% 10Y
Xetra, Closing price Tue, Feb 04 2025
+1.00 1.57%
ISIN
DE000A2YNT30
Symbol
ACT
Index
Industry

Key metrics

Market capitalization €657.39m
Enterprise Value €671.41m
P/E (TTM) P/E ratio 14.19
EV/FCF (TTM) EV/FCF 9.29
EV/Sales (TTM) EV/Sales 1.22
P/S ratio (TTM) P/S ratio 1.20
P/B ratio (TTM) P/B ratio 3.64
Dividend yield 1.86%
Last dividend (FY23) €1.20
Revenue growth (TTM) Revenue growth 0.08%
Revenue (TTM) Revenue €549.87m
EBIT (operating result TTM) EBIT €65.02m
Free Cash Flow (TTM) Free Cash Flow €72.27m
EPS (TTM) EPS €4.55
P/E forward 12.74
P/S forward 1.17
EV/Sales forward 1.20
Show more

Is Alzchem Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Alzchem Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Alzchem Group forecast:

5x Buy
100%

Analyst Opinions

5 Analysts have issued a Alzchem Group forecast:

Buy
100%

Financial data from Alzchem Group

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
550 550
0% 0%
100%
- Direct Costs 392 392
12% 12%
71%
157 157
49% 49%
29%
- Selling and Administrative Expenses 57 57
14% 14%
10%
- Research and Development Expense 9.46 9.46
-
2%
91 91
63% 63%
17%
- Depreciation and Amortization 26 26
3% 3%
5%
EBIT (Operating Income) EBIT 65 65
113% 113%
12%
Net Profit 46 46
68% 68%
8%

In millions EUR.

Don't miss a Thing! We will send you all news about Alzchem Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Alzchem Group Stock News

EQS
9 days ago
Im Zeitraum vom 20. bis einschließlich 24. Januar 2025 wurden insgesamt 7.659 Stückaktien der Alzchem Group AG im Rahmen des am 29. November 2024 angekündigten Aktienrückkaufprogramms erworben. Die Gesamtzahl der im Rahmen des Rückkaufs bislang erworbenen Aktien beträgt damit 40.662 Stück. Der Er...
More Alzchem Group News

Company Profile

AlzChem Group AG engages in the development, production, and marketing of chemical products. It operates through the following segments: Specialty Chemicals, Basics and Intermediates, and Other and Holding. The Specialty Chemicals segment focuses on the production and distribution of growth products that contain specialty chemicals such as CreAMINO, Creapure, BioSelect, Silzot, DYHARD, and Dormex. The Basics & Intermediates segment covers the production of basic and intermediate products. The Other & Holding segment comprises of services to the chemical parks in Trostberg and Hart. The company was founded on October 10, 1984 is headquartered in Trostberg, Germany.

Head office Germany
CEO Andreas Niedermaier
Employees 1,708
Founded 1984
Website www.alzchem.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today